UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023538
Receipt number R000027109
Scientific Title A Questionnaire Usability Survey of Generic Fentanyl Tape for 3 Days
Date of disclosure of the study information 2016/08/16
Last modified on 2016/09/30 08:54:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A Questionnaire Usability Survey of Generic Fentanyl Tape for 3 Days

Acronym

A Questionnaire Usability Survey of Generic Fentanyl Tape for 3 Days

Scientific Title

A Questionnaire Usability Survey of Generic Fentanyl Tape for 3 Days

Scientific Title:Acronym

A Questionnaire Usability Survey of Generic Fentanyl Tape for 3 Days

Region

Japan


Condition

Condition

healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In consideration of switching to fentanyl tape for 3 days of generic products, we must choose the tape that has not peeling, itching and discomfort of the application site and has good openability. In this study, we investigate the feeling of use and openability by questionnaire about bland-name and generic products that contains no agent component.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Openability, operability, Tackiness, Deciduous, Peeling property, skin feeling

Key secondary outcomes

Patients recommended degree


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

No need to know


Intervention

No. of arms

3

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

A sample of fentanyl tape application on abdominal, 3 days

Interventions/Control_2

A sample of fentanyl tape application on abdominal, 3 days

Interventions/Control_3

A sample of fentanyl tape application on abdominal, 3 days

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

60 years-old >=

Gender

Male and Female

Key inclusion criteria

Division of pharmacy staff in our hospital without this research member

Key exclusion criteria

Individuals who have had an allergy caused by tape or poultice
Individuals with a skin disease in application site
Individuals who are already using the other tape or poultice in the adaptive sites
Women who are or may be pregnant and nursing women
Individuals who have severe systemic illness with an expected life
Individuals who have severe liver dysfunction or severe renal dysfunction
Individuals and these families who have a conflict of interest
Individuals who are diagnosed as inappropriate for the trial

Target sample size

10


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroaki Araki

Organization

Ehime university hospital

Division name

Division of pharmacy

Zip code


Address

Shitsukawa 454, Toon, Ehime, Japan

TEL

089-960-5730

Email

haraki@m.ehime-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Akihiro Tanaka

Organization

Ehime university hospital

Division name

Division of pharmacy

Zip code


Address

Shitsukawa 454, Toon, Ehime, Japan

TEL

089-960-5731

Homepage URL


Email

tanaka.akihiro.mj@ehime-u.ac.jp


Sponsor or person

Institute

Ehime university hospital division of pharmacy

Institute

Department

Personal name



Funding Source

Organization

Ehime university hospital division of pharmacy

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

愛媛大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2016 Year 08 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 06 Month 23 Day

Date of IRB


Anticipated trial start date

2016 Year 08 Month 16 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 08 Month 08 Day

Last modified on

2016 Year 09 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027109


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name